Literature DB >> 2157882

Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.

G D Holland1, M J Henkemeyer, D A Kaehler, F M Hoffmann, R Risser.   

Abstract

The Drosophila melanogaster abl and the murine v-abl genes encode tyrosine protein kinases (TPKs) whose amino acid sequences are highly conserved. To assess functional conservation between the two gene products, we constructed Drosophila abl/v-abl-chimeric Abelson murine leukemia viruses. In these chimeric Abelson murine leukemia viruses, the TPK and carboxy-terminal regions of v-abl were replaced with the corresponding regions of D. melanogaster abl. The chimeric Abelson murine leukemia viruses were able to mediate morphological and oncogenic transformation of NIH 3T3 cells and were able to abrogate the interleukin-3 dependence of a lymphoid cell line. We also found that a virus that contained both TPK and carboxy-terminal Drosophila abl regions had no in vitro transforming activity for primary bone marrow cells and lacked the ability to induce tumors in susceptible mice. A virus that replaced only a portion of the v-abl TPK region with that of Drosophila abl had low activity in in vitro bone marrow transformation and tumorigenesis assays. These results indicate that the transforming functions of abl TPKs are only partially conserved through evolution. These results also imply that the TPK region of v-abl is a major determinant of its efficient lymphoid cell-transforming activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157882      PMCID: PMC249383          DOI: 10.1128/JVI.64.5.2226-2235.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors:  A Hermans; N Heisterkamp; M von Linden; S van Baal; D Meijer; D van der Plas; L M Wiedemann; J Groffen; D Bootsma; G Grosveld
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

2.  Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Authors:  C D Scher; R Siegler
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

3.  Lymphosarcoma: virus-induced thymic-independent disease in mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

4.  Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

5.  Recombinants within the tyrosine kinase region of v-abl and v-src identify a v-abl segment that confers lymphoid specificity.

Authors:  B Mathey-Prevot; D Baltimore
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  The Drosophila Abelson proto-oncogene homolog: identification of mutant alleles that have pleiotropic effects late in development.

Authors:  M J Henkemeyer; F B Gertler; W Goodman; F M Hoffmann
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

8.  Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus.

Authors:  P L Green; D A Kaehler; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Structure and origins of the HZ2-feline sarcoma virus.

Authors:  P J Bergold; J Y Wang; W D Hardy; V Littau; E Johnson; P Besmer
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  1 in total

1.  Phosphorylation of Enabled by the Drosophila Abelson tyrosine kinase regulates the in vivo function and protein-protein interactions of Enabled.

Authors:  A R Comer; S M Ahern-Djamali; J L Juang; P D Jackson; F M Hoffmann
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.